These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1095298)

  • 1. Two oral contraceptives with the same gestagen and different estrogen. A controlled clinical trial.
    Flodgaard D; Helles A; Jacobsen M
    Contraception; 1975 Jul; 12(1):77-88. PubMed ID: 1095298
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modifications in the menstrual pattern during use of hormonal contraceptives].
    de Sampaio LF; Novo NF; de Paiva ER
    Matern Infanc (Sao Paulo); 1974; 33(3):367-70. PubMed ID: 4466962
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new estrogen variant in the oral contraceptive Non-Ovlon].
    Sarembe B
    Dtsch Gesundheitsw; 1973; 28(5):223-7. PubMed ID: 4579102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amenorrhea, anovulation and oligomenorrhea due to use of oral contraceptives].
    James M; Rozenbaum H
    Concours Med; 1974 Mar; 96(10):1559-60, 1563-4, 1567-8. PubMed ID: 4619979
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal contraceptives in female rowers].
    Lisý Z
    Cas Lek Cesk; 1984 Aug; 123(35):1086-90. PubMed ID: 6498900
    [No Abstract]   [Full Text] [Related]  

  • 6. The oversuppression syndrome.
    Horowitz BJ; Solomkin M; Edelstein SW
    Obstet Gynecol; 1968 Mar; 31(3):387-9. PubMed ID: 5639193
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical results with a new low dose oral contraceptive utilizing norethindrone/ethinyl estradiol.
    Pasquale SA; Yuliano E
    Contraception; 1975 Nov; 12(5):495-503. PubMed ID: 1192736
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
    Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
    Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of lyndiol novem, a modernized hormonal contraceptive].
    Göran C
    Opusc Med; 1973; 18(4):180-2. PubMed ID: 4614998
    [No Abstract]   [Full Text] [Related]  

  • 13. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].
    Arnold M; Tóth I; Faredin I
    Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies on oral contraceptives--a randomized, doubleblind, crossover study of 4 different preparations (Anovlar mite, Lyndiol mite, Ovulen, and Volidan).
    Nilsson L; Sölvell L
    Acta Obstet Gynecol Scand; 1967; 46(S8):3-31. PubMed ID: 4229036
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet adhesiveness and lipoprotein lipase activity in controls and in subjects taking oral contraceptives.
    Ham JM; Rose R
    Am J Obstet Gynecol; 1969 Oct; 105(4):628-31. PubMed ID: 4898817
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
    Serup J; Bostofte E; Larsen S; Westergaard J
    Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2 oral contraceptives with the same gestagen and different estrogen. A controlled clinical trial].
    Flodgaard D; Helles A; Jacobsen M
    Ugeskr Laeger; 1975 Jan; 137(3):145-8. PubMed ID: 1094660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects and side-effects of 2 estrogen-lynesterenol combinations used in hormonal ovulation inhibition].
    Jacobs C; Heinen G; Schmal E
    Med Welt; 1974 Sep; 25(35):1351-3. PubMed ID: 4419263
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenocortical function of patients using oral contraceptives.
    Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
    Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.